| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Doximity, Inc. | 10%+ Owner | Class B Common Stock | 8.56M | $228M | $26.65 | Dec 2, 2021 | Direct |
| PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 4.47M | $9.97M | $2.23 | Jul 13, 2021 | Direct |
| Doximity, Inc. | 10%+ Owner | Class A Common Stock | 81.7K | $2.31M | $28.27 | Dec 2, 2021 | By: Khaled A. Nasr |
| Doximity, Inc. | 10%+ Owner | Class A Common Stock | 54.8K | $1.55M | $28.27 | Dec 2, 2021 | By: Keval Desai |
| PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 25.6K | $57K | $2.23 | Jul 13, 2021 | By Gilbert H. Kliman |
| PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 4.2K | $9.37K | $2.23 | Jul 13, 2021 | By: Khaled A. Nasr |
| PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 2.82K | $6.28K | $2.23 | Jul 13, 2021 | By: Keval Desai |
| Doximity, Inc. | 10%+ Owner | Class A Common Stock | 0 | $28.27 | Dec 2, 2021 | By: InterWest Management Partners X, LLC | |
| Doximity, Inc. | 10%+ Owner | Class A Common Stock | 0 | $28.27 | Dec 2, 2021 | Direct | |
| Doximity, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | Jun 28, 2021 | Direct | ||
| Doximity, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jun 28, 2021 | Direct | ||
| Doximity, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | Jun 28, 2021 | Direct | ||
| PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 0 | $2.23 | Jul 13, 2021 | By: InterWest Management Partners X, LLC |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DOCS | Doximity, Inc. | Dec 2, 2021 | 7 | $0 | 4 | Dec 6, 2021 | 10%+ Owner |
| DOCS | Doximity, Inc. | Nov 12, 2021 | 7 | $0 | 4 | Nov 15, 2021 | 10%+ Owner |
| PMVP | PMV Pharmaceuticals, Inc. | Jul 13, 2021 | 6 | $0 | 4 | Jul 14, 2021 | 10%+ Owner |
| DOCS | Doximity, Inc. | Jun 28, 2021 | 7 | -$105M | 4 | Jun 28, 2021 | 10%+ Owner |
| DOCS | Doximity, Inc. | Jun 23, 2021 | 0 | $0 | 3 | Jun 23, 2021 | 10%+ Owner |
| PMVP | PMV Pharmaceuticals, Inc. | May 10, 2021 | 6 | $0 | 4 | May 12, 2021 | 10%+ Owner |